Photodynamic therapy in treating patients with skin cancer

Journal of Drugs in Dermatology, May, 2007

Sponsors and Collaborators: Roswell Park Cancer Institute and National Cancer Institute (NCI). This randomized phase II trial is studying how well photodynamic therapy that includes aminolevulinic acid works in treating patients with skin cancer.

Condition                    Intervention                     Phase

Nonmelanomatous Skin Cancer  Drug: aminolevulinic acid        Phase II
Precancerous/Non-malignant   Procedure: laser therapy
  Condition                  Procedure: photodynamic therapy
                             Procedure: phototherapy

Study ID Numbers: CDR0000065494; RPCI-DS-96-55; NCI-G97-1224

ClinicalTrials.gov Identifier: NCT00002975